400 related articles for article (PubMed ID: 31497026)
1. Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation.
Hu G; Guo M; Xu J; Wu F; Fan J; Huang Q; Yang G; Lv Z; Wang X; Jin Y
Front Immunol; 2019; 10():1998. PubMed ID: 31497026
[TBL] [Abstract][Full Text] [Related]
2. Tailoring Nanomaterials for Targeting Tumor-Associated Macrophages.
Ovais M; Guo M; Chen C
Adv Mater; 2019 May; 31(19):e1808303. PubMed ID: 30883982
[TBL] [Abstract][Full Text] [Related]
3. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Fluorescent Hybrid Nanoparticles for Traceable Delivery of Glucocorticoids to Inflammatory Sites.
Napp J; Markus MA; Heck JG; Dullin C; Möbius W; Gorpas D; Feldmann C; Alves F
Theranostics; 2018; 8(22):6367-6383. PubMed ID: 30613305
[TBL] [Abstract][Full Text] [Related]
5. Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer.
Ponzoni M; Pastorino F; Di Paolo D; Perri P; Brignole C
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29973487
[TBL] [Abstract][Full Text] [Related]
6. Multivalent nanosystems: targeting monocytes/macrophages.
Poupot R; Goursat C; Fruchon S
Int J Nanomedicine; 2018; 13():5511-5521. PubMed ID: 30271144
[TBL] [Abstract][Full Text] [Related]
7. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
[TBL] [Abstract][Full Text] [Related]
8. Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug delivery.
Yurkin ST; Wang Z
Nanomedicine (Lond); 2017 Aug; 12(16):2007-2019. PubMed ID: 28745122
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for Cancer Targeting: Current and Future Directions.
Swain S; Sahu PK; Beg S; Babu SM
Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites.
Dong X; Chu D; Wang Z
Theranostics; 2017; 7(3):751-763. PubMed ID: 28255364
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of nanoparticulate systems for macrophage targeting.
Chellat F; Merhi Y; Moreau A; Yahia L
Biomaterials; 2005 Dec; 26(35):7260-75. PubMed ID: 16023200
[TBL] [Abstract][Full Text] [Related]
13. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
14. Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseases.
Schraa AJ; Everts M; Kok RJ; Asgeirsdóttir SA; Meijer DK; de Leij LF; Molema G
Biotechnol Annu Rev; 2002; 8():133-65. PubMed ID: 12436918
[TBL] [Abstract][Full Text] [Related]
15. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles.
Colino CI; Lanao JM; Gutierrez-Millan C
Front Immunol; 2020; 11():218. PubMed ID: 32194546
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases.
Singh A; Talekar M; Raikar A; Amiji M
J Control Release; 2014 Sep; 190():515-30. PubMed ID: 24747762
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.
Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995
[TBL] [Abstract][Full Text] [Related]
18. Yeast Microcapsule-Mediated Targeted Delivery of Diverse Nanoparticles for Imaging and Therapy via the Oral Route.
Zhou X; Zhang X; Han S; Dou Y; Liu M; Zhang L; Guo J; Shi Q; Gong G; Wang R; Hu J; Li X; Zhang J
Nano Lett; 2017 Feb; 17(2):1056-1064. PubMed ID: 28075596
[TBL] [Abstract][Full Text] [Related]
19. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
Huang D; He B; Mi P
Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
[TBL] [Abstract][Full Text] [Related]
20. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
